WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Mets Brain Tumors efficacy endpoints v2, MRI has types - With contrast - Without contrast - FLAIR, Time To Salvage Therapy In the Brain measured by Date of Salvage Therapy, Target lesion evaluated by Quantitative assessment, Organ specific lesion ID includes - Supratentorial: hemispheric (L, R) - Infratentorial: brain stem cerebellum, Sum of the product of all lesions includes Total area of each leasion, Target lesion evaluated by Quantitative assessment, Progression free survival (PFS) has subtypes Extracranial, Lung has histology - NSCLC - SCLC - other, Sum of longest diameters (SLD) has component Short axis for target lymph nodes, Tumor Response can be assessed with MacDonald, Non-target lesion evaluated by Qualitative Assessment, Measurable lesions has subtype Non-target lesion, Lesion classified as Enhancing, Existing lesion identified by Anatomical region, Regional includes Convection enhanced delivery, Tumor Response is assessed with CT, Enhancing classified as Measurable lesions, Sum of the product of all lesions includes Total area of each leasion, MacDonald has attributes RANO and MacDonald Attributes, Lesion classified as Existing lesion